Dr. Lars Ryden is a Senior Professor of Cardiology at the Karolinska Institute, Stockholm, Sweden. He specializes in internal medicine and cardiology, with a focus on arrhythmias, cardiac pacing, heart failure and cardiovascular disease related to diabetes. Glycemic control is important to prevent the development and progression of diabetic complications.
A series of experimental studies showed that incretin-based therapies have beneficial effects on diabetic complications, independent of their glucose-lowering abilities, which are mediated by anti-inflammatory and anti-oxidative stress properties. In this interaction, Dr. Lars Ryden talks about "Incretin-Based Therapy For Diabetes Mellitus."
